6031 related articles for article (PubMed ID: 17462670)
1. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
[TBL] [Abstract][Full Text] [Related]
4. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.
Vamos E; Pardutz A; Klivenyi P; Toldi J; Vecsei L
J Neurol Sci; 2009 Aug; 283(1-2):21-7. PubMed ID: 19268309
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders.
Zádori D; Klivényi P; Szalárdy L; Fülöp F; Toldi J; Vécsei L
J Neurol Sci; 2012 Nov; 322(1-2):187-91. PubMed ID: 22749004
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection.
Sas K; Szabó E; Vécsei L
Molecules; 2018 Jan; 23(1):. PubMed ID: 29342113
[TBL] [Abstract][Full Text] [Related]
7. Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesis.
Poon HF; Shepherd HM; Reed TT; Calabrese V; Stella AM; Pennisi G; Cai J; Pierce WM; Klein JB; Butterfield DA
Neurobiol Aging; 2006 Jul; 27(7):1020-34. PubMed ID: 15996793
[TBL] [Abstract][Full Text] [Related]
8. Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons.
Fatokun AA; Smith RA; Stone TW
Brain Res; 2008 Jun; 1215():200-7. PubMed ID: 18486115
[TBL] [Abstract][Full Text] [Related]
9. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
Silva-Adaya D; Pérez-De La Cruz V; Herrera-Mundo MN; Mendoza-Macedo K; Villeda-Hernández J; Binienda Z; Ali SF; Santamaría A
J Neurochem; 2008 May; 105(3):677-89. PubMed ID: 18194214
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases.
Trushina E; McMurray CT
Neuroscience; 2007 Apr; 145(4):1233-48. PubMed ID: 17303344
[TBL] [Abstract][Full Text] [Related]
11. [The role for oxidative stress in neurodegenerative diseases].
Shibata N; Kobayashi M
Brain Nerve; 2008 Feb; 60(2):157-70. PubMed ID: 18306664
[TBL] [Abstract][Full Text] [Related]
12. Role of mitochondrial dysfunction in Alzheimer's disease.
Castellani R; Hirai K; Aliev G; Drew KL; Nunomura A; Takeda A; Cash AD; Obrenovich ME; Perry G; Smith MA
J Neurosci Res; 2002 Nov; 70(3):357-60. PubMed ID: 12391597
[TBL] [Abstract][Full Text] [Related]
13. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms.
Castellano-Gonzalez G; Jacobs KR; Don E; Cole NJ; Adams S; Lim CK; Lovejoy DB; Guillemin GJ
Neurotox Res; 2019 Apr; 35(3):530-541. PubMed ID: 30666558
[TBL] [Abstract][Full Text] [Related]
14. Age related mitochondrial degenerative disorders in humans.
Reeve AK; Krishnan KJ; Turnbull DM
Biotechnol J; 2008 Jun; 3(6):750-6. PubMed ID: 18512864
[TBL] [Abstract][Full Text] [Related]
15. Neuropharmacology of quinolinic and kynurenic acids.
Stone TW
Pharmacol Rev; 1993 Sep; 45(3):309-79. PubMed ID: 8248282
[TBL] [Abstract][Full Text] [Related]
16. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
[TBL] [Abstract][Full Text] [Related]
17. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
Tan L; Yu JT; Tan L
J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
[TBL] [Abstract][Full Text] [Related]
18. Disturbances of the functioning of endoplasmic reticulum: a key mechanism underlying neuronal cell injury?
Paschen W; Doutheil J
J Cereb Blood Flow Metab; 1999 Jan; 19(1):1-18. PubMed ID: 9886350
[TBL] [Abstract][Full Text] [Related]
19. Aging, energy, and oxidative stress in neurodegenerative diseases.
Beal MF
Ann Neurol; 1995 Sep; 38(3):357-66. PubMed ID: 7668820
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities.
Schwarcz R; Pellicciari R
J Pharmacol Exp Ther; 2002 Oct; 303(1):1-10. PubMed ID: 12235226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
